» Articles » PMID: 35105320

Bronchoalveolar Lavage Lymphocytosis in Hypersensitivity Pneumonitis: a Retrospective Cohort Analysis with Elimination of Incorporation Bias

Overview
Journal BMC Pulm Med
Publisher Biomed Central
Specialty Pulmonary Medicine
Date 2022 Feb 2
PMID 35105320
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Recent studies support the diagnostic role of bronchoalveolar lavage lymphocytosis (BALL) in patients with suspected hypersensitivity pneumonitis (HP). Our study aim was to determine the spectrum of BALL findings with elimination of incorporation bias in non-fibrotic and fibrotic patients and assess correlates of positive BALL cut-off and BALL association with long-term outcomes in those with fibrotic disease (f-HP).

Methods: A single-center retrospective cohort study was pursued of patients undergoing diagnostic bronchoscopy for interstitial lung disease. Strict study enrollment was based on recent ATS/JRS/ALAT diagnostic guidance meeting 'moderate' or higher diagnostic confidence. BALL findings were assessed in both fibrotic and non-fibrotic HP patients with regression and survival analysis pursued for correlates of positive BALL cut-off and long-term outcome.

Results: A total of 148 patients (88 fibrotic and 60 non-fibrotic) meeting moderate or higher diagnostic confidence were included. Median BALL in f-HP was 15% compared to 19% in non-fibrotic patients, with only 28% of f-HP meeting diagnostic cut-off (≥ 30%) compared to 41% of non-fibrotic. For f-HP, centrilobular nodules on computed tomography was positively correlated with a diagnostic BALL (OR 4.07; p = 0.018) while honeycombing was negatively correlated (OR 6.9 × e; p = 0.001). Higher BALL was also associated with lower all-cause mortality (HR 0.98; p = 0.015).

Conclusion: With elimination of incorporation bias, most patients with well-described HP did not meet diagnostic BALL thresholds. Higher BALL was associated with better long-term survival in those with fibrosis, but its diagnostic role may be more additive than characteristic or distinguishing.

Citing Articles

Prognostic factors of progressive fibrotic hypersensitivity pneumonitis: a large, retrospective, multicentre, observational cohort study.

Cano-Jimenez E, Gomez A, Velez Segovia E, Aburto Barrenechea M, Sellares Torres J, Francesqui J ERJ Open Res. 2024; 10(1).

PMID: 38410707 PMC: 10895428. DOI: 10.1183/23120541.00405-2023.


Diagnosis of Fibrotic Hypersensitivity Pneumonitis: Is There a Role for Biomarkers?.

Pereira J, Fernandes V, Alfaro T, Freitas S, Cordeiro C Life (Basel). 2023; 13(2).

PMID: 36836922 PMC: 9966605. DOI: 10.3390/life13020565.


Evaluation of cases with hypersensitivity pneumonia: 10 year analysis.

Koyuncu A, Sari G, Simsek C Clin Respir J. 2023; 17(4):329-338.

PMID: 36780898 PMC: 10113273. DOI: 10.1111/crj.13598.


Challenges in the Diagnosis and Management of Fibrotic Hypersensitivity Pneumonitis: A Practical Review of Current Approaches.

Moua T, Petnak T, Charokopos A, Baqir M, Ryu J J Clin Med. 2022; 11(6).

PMID: 35329800 PMC: 8955902. DOI: 10.3390/jcm11061473.

References
1.
Schuyler M, Cormier Y . The diagnosis of hypersensitivity pneumonitis. Chest. 1997; 111(3):534-6. DOI: 10.1378/chest.111.3.534. View

2.
Raghu G, Remy-Jardin M, Ryerson C, Myers J, Kreuter M, Vasakova M . Diagnosis of Hypersensitivity Pneumonitis in Adults. An Official ATS/JRS/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med. 2020; 202(3):e36-e69. PMC: 7397797. DOI: 10.1164/rccm.202005-2032ST. View

3.
Adderley N, Humphreys C, Barnes H, Ley B, Premji Z, Johannson K . Bronchoalveolar lavage fluid lymphocytosis in chronic hypersensitivity pneumonitis: a systematic review and meta-analysis. Eur Respir J. 2020; 56(2). DOI: 10.1183/13993003.00206-2020. View

4.
Ojanguren I, Morell F, Ramon M, Villar A, Romero C, Cruz M . Long-term outcomes in chronic hypersensitivity pneumonitis. Allergy. 2018; 74(5):944-952. DOI: 10.1111/all.13692. View

5.
De Sadeleer L, Hermans F, De Dycker E, Yserbyt J, Verschakelen J, Verbeken E . Impact of BAL lymphocytosis and presence of honeycombing on corticosteroid treatment effect in fibrotic hypersensitivity pneumonitis: a retrospective cohort study. Eur Respir J. 2020; 55(4). DOI: 10.1183/13993003.01983-2019. View